1. Home
  2. TSBK vs SLN Comparison

TSBK vs SLN Comparison

Compare TSBK & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Timberland Bancorp Inc.

TSBK

Timberland Bancorp Inc.

HOLD

Current Price

$42.18

Market Cap

317.7M

Sector

Finance

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.75

Market Cap

300.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSBK
SLN
Founded
1915
1994
Country
United States
United Kingdom
Employees
N/A
88
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.7M
300.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
TSBK
SLN
Price
$42.18
$6.75
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$42.60
AVG Volume (30 Days)
17.9K
226.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.87%
N/A
EPS Growth
21.93
N/A
EPS
1.94
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.96
$4.19
52 Week High
$43.58
$8.40

Technical Indicators

Market Signals
Indicator
TSBK
SLN
Relative Strength Index (RSI) 52.66 52.51
Support Level $37.50 $5.77
Resistance Level $41.87 $7.05
Average True Range (ATR) 1.09 0.54
MACD 0.09 0.06
Stochastic Oscillator 51.73 68.46

Price Performance

Historical Comparison
TSBK
SLN

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: